Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Biocon Eyes 'Foothold To Stronghold' For (b)Humira In US, Pauses RH-Insulin Program
Feb 19 2024
•
By
Anju Ghangurde
Slow gains for Humira Rivals But Opportunities In Store • Source: Shutterstock
Keep up with the top pharma business news of the week. On the go.
Scrip brings you a weekly bulletin of top picks.
More from Business
More from Scrip